Gilead Sciences (GILD 0.69%), a major player in the biotechnology sector, reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 11, that topped analysts' consensus estimates. Adjusted earnings per share of $1.90 came in well ahead of the estimated $1.74.

Gold surged to $2,943, hitting record highs before facing resistance. A weak closing price increases the chances that a bearish reversal may follow, with $2,882 as key near-term support.

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q1 2025 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Doug Cooper - Beacon Securities Julian Hung - Stifel Bill Sutherland - The Benchmark Company Operator Thank you for standing by. This is the conference operator.

MILWAUKEE--(BUSINESS WIRE)--Zurn Elkay Water Solutions Announces Launch of Public Offering of Common Stock by Selling Stockholder.

BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) today reported financial results for the fourth quarter and full year 2024.

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual Aerospace & Defense Conference at the Ritz-Carlton – Pentagon City in Arlington, Va. on Thursday, February 13, at 9:15 a.m. Eastern Time. A live webcast of Teledyne's presentation may be accessed via the company's website at www.teledyne.com/investors/events-an.

DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (“SEC”). USA Compression's Annual Report on Form 10-K is available through its website at www.usacompression.com in the Investor Relations section under SEC Filings, as well as on the SEC's website at sec.gov. Interested investors may obtain a hard copy of.

Ford CEO Jim Farley said at an analyst conference that while President Trump wants to help automakers, his Canada and Mexico tariffs could "blow a hole" in the U.S. auto industry.

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that, in connection with the appointment of the Company's new Chief Medical Officer, Richard Markus, M.D., Ph.D., the Compensation Committee of the Company's Board of Directors granted Dr. Markus an option to purchase 305,328 shares of the Company's common stock.

Loews: At $87 It's Undervalued Given Management's Persistent History Of Success

Mexican telecommunications giant America Movil on Tuesday reported a 48% fall in its fourth-quarter net profit, well below analysts' expectations, with the company citing foreign-exchange losses even as its revenues rose.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tidal Financial Group and Plato's Philosophy LLC announce the closure and liquidation of the Meet Kevin Pricing Power ETF (NYSE Arca: PP), effective February 28, 2025. This decision follows a thorough evaluation and was determined to be in the best interests of the fund and its shareholders.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FTAI Aviation Ltd. (NASDAQ: FTAI) between July 23, 2024, and January 15, 2025, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.

ATLANTA--(BUSINESS WIRE)--NCR Voyix Corporation (NYSE: VYX), a leading global provider of digital commerce solutions, today announced the appointment of Darren Wilson as its new EVP & President, Retail and Payments, effective immediately. “Darren is a proven, growth-oriented leader and trusted colleague who has already added tremendous benefit since joining NCR Voyix last year,” said James G. Kelly, President & CEO, NCR Voyix. “I look forward to working with Darren as we continue to dri.

NEW YORK--(BUSINESS WIRE)--iHeartMedia, Inc. (NASDAQ: IHRT) announced today that on Thursday February 27th, 2025, it will issue financial results for the quarter and year ending December 31, 2024. The company will conduct a conference call at 4:30 p.m. (ET), following the release of its earnings announcement, to discuss its financial results and business outlook. A live audio webcast of the call will be available on the Investors homepage of iHeartMedia's website (https://investors.iheartmedia.

DALLAS--(BUSINESS WIRE)--HF Sinclair Corporation (the “Corporation”) (NYSE: DINO) today announced that it will redeem $195,000,000 aggregate principal amount of its outstanding 5.875% Senior Notes due 2026 (the “Notes”). The redemption price for the Notes will equal the greater of (i) 100% of the principal amount of the Notes to be redeemed and (ii) the “make-whole” redemption premium specified in the indenture, as supplemented, governing the Notes, plus, in either case, accrued and unpaid inte.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of dia.

ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the fourth quarter and full year of 2024 after the market closes on Tuesday, February 25, 2025.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ:IAS) between March 2, 2023 and February 27, 2024, inclusive (the "Class Period"). A class action lawsuit has already been filed.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Leslie M. Turner to its Board of Directors.